Skip to content

The Application of Best Evidence–Based Gastrointestinal Function Management in Patients Undergoing Radical Cystectomy

The Application of Best Evidence–Based Gastrointestinal Function Management in Patients Undergoing Radical Cystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111592
Enrollment
Unknown
Registered
2025-11-03
Start date
2025-11-09
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer

Interventions

Intervention Group:Preoperative 1.For patients with severe malnutrition, provide preoperative nutritional support, preferably via the oral route, three times daily. 2.One day before surgery, administe
there is no need to lie flat without a pillow. Ambulate within 24 hours postoperatively and gradually increase activity daily. 11. For patients undergoing orthotopic neobladder surgery, maintain exter

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed diagnosis of bladder cancer; 2.Assessed as meeting the surgical indications for radical cystectomy; 3.Age >= 18 years; 4.Patients have provided informed consent and are willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Severe cognitive or mental disorders; 2.Patients with other major comorbidities: such as those with advanced cancer or end-stage organ failure, whose severe conditions may affect the study outcomes; 3.Individuals with active implantable devices (e.g., cardiac pacemakers, implantable cardioverter-defibrillators, or neurostimulators), for whom electrical stimulation therapy may cause device malfunction or interfere with treatment safety due to current disruption; 4.Those with skin lesions at the acupoint sites, making it unsuitable to attach electrode patches.

Design outcomes

Primary

MeasureTime frame
Incidence of Gastrointestinal Dysfunction;

Secondary

MeasureTime frame
Severity of Gastrointestinal Dysfunction;Incidence of postoperative nausea, vomiting, abdominal pain, bloating, diarrhea, and constipation.;Time to First Postoperative Oral Intake;Time to First Postoperative Flatus;Length of Postoperative Hospital Stay;Implementation Status and Completion Rate of Interventions (e.g., Gum Chewing, Auricular Point Pressing, Early Ambulation);

Countries

China

Contacts

Public ContactDai Yumei

Fudan University Shanghai Cancer Center

daiyumeifudan@163.com+86 182 5073 1125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026